Tilray Inc (NASDAQ:TLRY – Get Free Report)’s stock price was up 1.4% during mid-day trading on Monday . The stock traded as high as $1.77 and last traded at $1.77. Approximately 2,569,867 shares changed hands during mid-day trading, a decline of 90% from the average daily volume of 25,098,781 shares. The stock had previously closed at $1.74.
Tilray Stock Performance
The company has a market cap of $1.39 billion, a P/E ratio of -4.11 and a beta of 2.13. The company has a 50 day moving average price of $1.82 and a 200-day moving average price of $1.87. The company has a quick ratio of 1.42, a current ratio of 2.27 and a debt-to-equity ratio of 0.10.
Tilray (NASDAQ:TLRY – Get Free Report) last released its quarterly earnings results on Monday, July 29th. The company reported ($0.04) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.02) by ($0.02). Tilray had a negative return on equity of 2.63% and a negative net margin of 30.26%. The business had revenue of $229.90 million during the quarter, compared to the consensus estimate of $226.20 million. During the same period in the previous year, the company posted ($0.15) EPS. The company’s revenue for the quarter was up 24.8% compared to the same quarter last year. Equities analysts expect that Tilray Inc will post -0.16 EPS for the current fiscal year.
Institutional Inflows and Outflows
About Tilray
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.
Featured Articles
- Five stocks we like better than Tilray
- What Makes a Stock a Good Dividend Stock?
- How Much Can You Make in Stocks in One Month?
- The How and Why of Investing in Gold Stocks
- This Is the Top Large-Cap Stock Insiders Are Buying
- How to Invest in Blue Chip Stocks
- Capitalize on Micron’s 24% Drop—Wall Street Eyes Major Upside
Receive News & Ratings for Tilray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilray and related companies with MarketBeat.com's FREE daily email newsletter.